Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,030 | 70 | 98.9% |
| Education | $11.56 | 1 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $452.82 | 31 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $141.14 | 10 | $0 (2022) |
| Mylan Specialty L.P. | $85.64 | 5 | $0 (2022) |
| Novo Nordisk Inc | $70.54 | 4 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $55.76 | 4 | $0 (2019) |
| PFIZER INC. | $51.77 | 4 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $49.90 | 3 | $0 (2021) |
| Sunovion Pharmaceuticals Inc. | $48.37 | 4 | $0 (2019) |
| Philips Electronics North America Corporation | $40.00 | 3 | $0 (2020) |
| Shire North American Group Inc | $18.77 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $84.00 | 5 | AstraZeneca Pharmaceuticals LP ($59.74) |
| 2021 | $112.69 | 8 | AstraZeneca Pharmaceuticals LP ($41.98) |
| 2020 | $221.48 | 12 | GlaxoSmithKline, LLC. ($106.15) |
| 2019 | $436.95 | 34 | GlaxoSmithKline, LLC. ($211.60) |
| 2018 | $69.61 | 5 | GlaxoSmithKline, LLC. ($42.96) |
| 2017 | $117.13 | 7 | GlaxoSmithKline, LLC. ($61.83) |
All Payment Transactions
71 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/05/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/09/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $12.17 | General |
| Category: Respiratory | ||||||
| 02/28/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/02/2022 | Mylan Specialty L.P. | Yupelri (Drug) | Food and Beverage | In-kind items and services | $24.26 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 01/26/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/01/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.19 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/01/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.42 | General |
| Category: RESPIRATORY | ||||||
| 09/09/2021 | Mylan Specialty L.P. | Yupelri (Drug) | Food and Beverage | In-kind items and services | $11.70 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 06/07/2021 | Mylan Specialty L.P. | Yupelri (Drug), Perforomist | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 05/19/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $12.36 | General |
| Category: RESPIRATORY | ||||||
| 03/17/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: RESPIRATORY | ||||||
| 02/24/2021 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: Respiratory | ||||||
| 02/24/2021 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Education | In-kind items and services | $11.56 | General |
| Category: Respiratory | ||||||
| 11/19/2020 | GlaxoSmithKline, LLC. | ANORO ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $24.66 | General |
| Category: RESPIRATORY | ||||||
| 10/06/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.33 | General |
| Category: RESPIRATORY | ||||||
| 09/29/2020 | Philips Electronics North America Corporation | (8874) inCourage (Device) | Food and Beverage | Cash or cash equivalent | $11.34 | General |
| Category: Dental and Oral Health | ||||||
| 08/05/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.61 | General |
| Category: RESPIRATORY | ||||||
| 07/22/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $22.84 | General |
| Category: RESPIRATORY | ||||||
| 06/10/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: RESPIRATORY | ||||||
| 03/12/2020 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: Diabetes | ||||||
| 03/06/2020 | Mylan Specialty L.P. | Yupelri (Drug), Perforomist | Food and Beverage | In-kind items and services | $21.84 | General |
| Category: Respiratory and Allergy | ||||||
| 03/03/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/14/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: RESPIRATORY | ||||||
| 02/10/2020 | Philips Electronics North America Corporation | (8874) inCourage (Device) | Food and Beverage | Cash or cash equivalent | $14.23 | General |
| Category: Dental and Oral Health | ||||||
| 02/05/2020 | Resmed Corp | Astral (Device) | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: Devices | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2020 | 11 | 938 | 1,341 | $251,981 | $79,888 |
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 537 | 882 | $189,630 | $56,960 | 30.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 30 | 86 | $18,077 | $6,436 | 35.6% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 31 | 31 | $12,803 | $3,590 | 28.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 28 | 28 | $6,552 | $3,025 | 46.2% |
| 99497 | Advance care planning by the physician or other qualified health care professional | Office | 2020 | 31 | 31 | $5,115 | $2,506 | 49.0% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 31 | 32 | $3,505 | $2,150 | 61.3% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 21 | 22 | $6,358 | $1,946 | 30.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 12 | 12 | $4,788 | $1,567 | 32.7% |
| 94060 | Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration | Facility | 2020 | 77 | 77 | $2,079 | $665.88 | 32.0% |
| 94726 | Determination of lung volumes using plethysmography | Facility | 2020 | 69 | 69 | $1,725 | $593.05 | 34.4% |
| 94729 | Measurement of lung diffusing capacity | Facility | 2020 | 71 | 71 | $1,349 | $448.62 | 33.3% |
About Dr. Richard Durham, MD
Dr. Richard Durham, MD is a Pulmonary Disease healthcare provider based in Buckeye, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1528010220.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Richard Durham, MD has received a total of $1,042 in payments from pharmaceutical and medical device companies, with $84.00 received in 2022. These payments were reported across 71 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($1,030).
As a Medicare-enrolled provider, Durham has provided services to 938 Medicare beneficiaries, totaling 1,341 services with total Medicare billing of $79,888. Data is available for 1 year (2020–2020), covering 11 distinct procedure/service records.
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Pulmonary Disease
- Location Buckeye, WV
- Active Since 05/17/2006
- Last Updated 07/06/2020
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1528010220
Products in Payments
- TRELEGY ELLIPTA (Drug) $263.94
- BREO (Drug) $117.64
- FARXIGA (Drug) $89.20
- Yupelri (Drug) $85.64
- XARELTO (Drug) $55.76
- LONHALA MAGNAIR (Drug) $48.37
- LYRICA (Drug) $40.60
- BREZTRI (Drug) $39.96
- STIOLTO RESPIMAT (Drug) $35.20
- Tresiba (Drug) $32.89
- SHINGRIX (Biological) $31.49
- (8874) inCourage (Device) $25.57
- ANORO ELLIPTA (Drug) $24.66
- GLASSIA (Biological) $18.77
- Astral (Device) $15.78
- Ozempic (Drug) $15.13
- ANORO (Drug) $15.09
- STIOLTO (Drug) $14.70
- inCourage (Device) $14.43
- FASENRA (Drug) $11.98
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.